- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Biosimilar Rituximab; Turning Back Time on EHRs; OTC Cough Products for Kids
Sandoz announced it will no longer pursue FDA approval for its proposed biosimilar rituximab; when it comes time to set the clocks back an hour for daylight saving time, hospitals opt for paper records during the night shift to compensate for challenges with electronic health records; new research on the effectiveness of over-the-counter (OTC) medicines finds little evidence that these products will relieve a child’s symptoms when sick.
Sandoz Abandoning Biosimilar Rituximab in the United States
After receiving a Complete Response Letter from the FDA for its proposed biosimilar rituximab, Sandoz has re-evaluated the environment and decided it will no longer pursue FDA approval for GP2013. The American Journal of Managed Care®’s The Center for Biosimilars® reported that Sandoz does not believe it can generate the data required before “patient and market place needs” in the United States are “satisfied.” Celltrion’s CT-P10 has already received a recommendation from an FDA advisory panel to be approved.
Setting the Clocks Back Challenges EHRs
It happens every year, and yet when it comes time to set the clocks back an hour for daylight saving time, hospitals opt for paper records during the night shift to compensate for challenges with electronic health records. According to Kaiser Health News, information entered from 1 am to 2 am will likely be deleted when the clock sets back to 1 am and hospitals avoid software glitches by turning the software off and using paper charts for an hour. Care delivery also slows down during the hour.
Questioning the Use of OTC Products in Sick Children
New research on the effectiveness of over-the-counter (OTC) cough and cold medicines finds little evidence that these products will relieve a child’s symptoms when sick. According to The New York Times, a review in The BMJ highlighted that there are actually risks in using OTC medications in young children. The American Academy of Pediatrics recommends against using OTC cough and cold preparations in children under age 6. The FDA only recommends against use in children under age 2. Instead, pediatricians recommend offering plenty of fluids, ibuprofen or acetaminophen, and honey (for children older than 1 year).
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Managed Care Reflections: A Q&A With Melinda B. Buntin, PhD
June 2nd 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The June issue features a conversation with Melinda B. Buntin, PhD, a health economist and a Bloomberg Distinguished Professor at the Johns Hopkins Bloomberg School of Public Health and Carey Business School.
Read More
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
